Medical Diagnostic Kit Maker Meridian Bioscience, Inc. Sees Q1 Below Estimates; Cuts FY Rev View

Jan 15 (Reuters) - Medical diagnostic kit maker Meridian Bioscience Inc's (VIVO.O) projected lower-than-expected first-quarter earnings and cut its revenue outlook for the year, as the strong dollar was hurting its European diagnostics sales.
MORE ON THIS TOPIC